State of progress in treating cystic fibrosis respiratory disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1186/1741-7015-10-88.pdf
Reference152 articles.
1. Cystic Fibrosis Foundation Patient Registry: 2010 Annual Data Report. Bethesda, MD. 2011
2. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC, Collins FS: Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989, 245 (4922): 1059-1065. 10.1126/science.2772657.
3. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989, 245 (4922): 1066-1073. 10.1126/science.2475911.
4. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science. 1989, 245 (4922): 1073-1080. 10.1126/science.2570460.
5. Collins FS: Cystic fibrosis: molecular biology and therapeutic implications. Science. 1992, 256 (5058): 774-779. 10.1126/science.1375392.
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Decellularized extracellular matrix for three-dimensional bioprinted in vitro disease modeling;International Journal of Bioprinting;2024-01-16
2. 18. Chronic Respiratory Diseases;Chronic Disease Epidemiology, Prevention, and Control, 5th edition;2023-01
3. Use of mucoactive agents in cystic fibrosis: A consensus survey of Italian specialists;Health Science Reports;2022-06-06
4. The use of targeted therapy lumacaftor/ivacaftor in patients with cystic fibrosis;Meditsinskiy sovet = Medical Council;2022-04-06
5. Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis;Bratislava Medical Journal;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3